SARAH SLOCUM: Open Payments
NPI 1851640155 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 30 payments from 12 companies in 2025. Trend: 2023 $800 · 2024 $617 · 2025 $939
Food & beverage: $782Education: $157
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $181 |
| Astellas Pharma US Inc | 2 | $157 |
| Janssen Biotech, Inc. | 4 | $123 |
| Endo USA, Inc. | 1 | $96 |
| UROGEN PHARMA, INC. | 2 | $77 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $65 |
| ABBVIE INC. | 3 | $52 |
| DENTSPLY IH AB | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
Products named: GEMTESA, XIAFLEX, JELMYTO, RYBREVANT, ERLEADA, LOFRIC, PLUVICTO, Personal Catheter Intermittent Catheter.
Industry payments across IN — which companies pay providers there.
